1-5 of 5
Carlo Heirman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression

Eva De Smedt, Ken Maes, Stefaan Verhulst, Hui Lui, Alboukadel Kassambara, Anke Maes, Nicolas Robert, Carlo Heirman, Andrew Cakana, Dirk Hose, Karine Breckpot, Leo A. van Grunsven, Kim De Veirman, Eline Menu, Karin Vanderkerken, Jérôme Moreaux, Elke De Bruyne
Journal: Cancer Research
Cancer Res (2018) 78 (5): 1155–1168.
https://doi.org/10.1158/0008-5472.CAN-17-1544
Published: 28 February 2018
View article titled, Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression
Open the PDF for Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression in another window
Includes: Supplementary data
Journal Articles

Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy

Sandra Van Lint, Cleo Goyvaerts, Sarah Maenhout, Lode Goethals, Aurélie Disy, Daphné Benteyn, Joeri Pen, Aude Bonehill, Carlo Heirman, Karine Breckpot, Kris Thielemans
Journal: Cancer Research
Cancer Res (2012) 72 (7): 1661–1671.
https://doi.org/10.1158/0008-5472.CAN-11-2957
Published: 01 April 2012
View article titled, Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy
Open the PDF for Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy in another window
Journal Articles

Proinflammatory Characteristics of SMAC/DIABLO-Induced Cell Death in Antitumor Therapy

Perpetua U. Emeagi, Sandra Van Lint, Cleo Goyvaerts, Sarah Maenhout, Anje Cauwels, Iain A. McNeish, Tomas Bos, Carlo Heirman, Kris Thielemans, Joeri L. Aerts, Karine Breckpot
Journal: Cancer Research
Cancer Res (2012) 72 (6): 1342–1352.
https://doi.org/10.1158/0008-5472.CAN-11-2400
Published: 14 March 2012
View article titled, Proinflammatory Characteristics of SMAC/DIABLO-Induced Cell Death in Antitumor Therapy
Open the PDF for Proinflammatory Characteristics of SMAC/DIABLO-Induced Cell Death in Antitumor Therapy in another window
Includes: Supplementary data
Journal Articles

Efficient Presentation of Known HLA Class II-restricted MAGE-A3 Epitopes by Dendritic Cells Electroporated with Messenger RNA Encoding an Invariant Chain with Genetic Exchange of Class II-associated Invariant Chain Peptide

Aude Bonehill, Carlo Heirman, Sandra Tuyaerts, Annelies Michiels, Yi Zhang, Pierre van der Bruggen, Kris Thielemans
Journal: Cancer Research
Cancer Res (2003) 63 (17): 5587–5594.
Published: 18 September 2003
View article titled, Efficient Presentation of Known HLA Class II-restricted MAGE-A3 Epitopes by Dendritic Cells Electroporated with Messenger RNA Encoding an Invariant Chain with Genetic Exchange of Class II-associated Invariant Chain Peptide
Open the PDF for Efficient Presentation of Known HLA Class II-restricted MAGE-A3 Epitopes by Dendritic Cells Electroporated with Messenger RNA Encoding an Invariant Chain with Genetic Exchange of Class II-associated Invariant Chain Peptide in another window
Journal Articles

A MAGE-A3 Peptide Presented by HLA-DP4 Is Recognized on Tumor Cells by CD4+ Cytolytic T Lymphocytes

Erwin S. Schultz, Bernard Lethé, César L. Cambiaso, Jacques Van Snick, Pascal Chaux, Jurgen Corthals, Carlo Heirman, Kris Thielemans, Thierry Boon, Pierre van der Bruggen
Journal: Cancer Research
Cancer Res (2000) 60 (22): 6272–6275.
Published: 15 November 2000
View article titled, A MAGE-A3 Peptide Presented by HLA-DP4 Is Recognized on Tumor Cells by CD4<sup>+</sup> Cytolytic T Lymphocytes
Open the PDF for A MAGE-A3 Peptide Presented by HLA-DP4 Is Recognized on Tumor Cells by CD4<sup>+</sup> Cytolytic T Lymphocytes in another window